You just read:

Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility

News provided by

Galderma

Oct 09, 2019, 08:07 ET